James W. Bogenpohl

683 total citations
12 papers, 513 citations indexed

About

James W. Bogenpohl is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Neurology. According to data from OpenAlex, James W. Bogenpohl has authored 12 papers receiving a total of 513 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cellular and Molecular Neuroscience, 6 papers in Molecular Biology and 4 papers in Neurology. Recurrent topics in James W. Bogenpohl's work include Neuroscience and Neuropharmacology Research (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Neurological disorders and treatments (3 papers). James W. Bogenpohl is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Neuroinflammation and Neurodegeneration Mechanisms (4 papers) and Neurological disorders and treatments (3 papers). James W. Bogenpohl collaborates with scholars based in United States and Canada. James W. Bogenpohl's co-authors include Yoland Smith, Thomas Wichmann, Colin L. Stewart, Russell N. Van Gelder, Louis J. Muglia, Rachel Wevrick, Erik D. Herzog, С. В. Козлов, John B. Hogenesch and David Alagille and has published in prestigious journals such as Nature Genetics, Brain and The Journal of Comparative Neurology.

In The Last Decade

James W. Bogenpohl

12 papers receiving 508 citations

Peers

Countries citing papers authored by James W. Bogenpohl

Since Specialization

Citations

This map shows the geographic impact of James W. Bogenpohl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Bogenpohl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Bogenpohl more than expected).

Fields of papers citing papers by James W. Bogenpohl

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Bogenpohl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Bogenpohl. The network helps show where James W. Bogenpohl may publish in the future.

Co-authorship network of co-authors of James W. Bogenpohl

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Bogenpohl. A scholar is included among the top collaborators of James W. Bogenpohl based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Bogenpohl. James W. Bogenpohl is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work	Indexed citations
1	Olfactory dysfunction in the 3xTg-AD model of Alzheimer’s disease 2021 ·IBRO Neuroscience Reports ·Darlene A. Mitrano, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), James W. Bogenpohl, (unknown), (unknown)	16
2	Chloride intracellular channel 4 (CLIC4) expression profile in the mouse medial prefrontal cortex and its regulation by ethanol 2021 ·Alcoholism Clinical and Experimental Research ·James W. Bogenpohl, (unknown), (unknown), (unknown), Michael F. Miles	4
3	Cross-Species Co-analysis of Prefrontal Cortex Chronic Ethanol Transcriptome Responses in Mice and Monkeys 2019 ·Frontiers in Molecular Neuroscience ·James W. Bogenpohl, Maren L. Smith, Sean P. Farris, Catherine I. Dumur, Marcelo F. Lopez, Howard C. Becker, Kathleen A. Grant, Michael F. Miles	21
4	Group II metabotropic glutamate receptor interactions with NHERF scaffold proteins: Implications for receptor localization in brain 2017 ·Neuroscience ·(unknown), Maryse Paquet, James W. Bogenpohl, Rachel E. Rodin, C. Chris Yun, Edward J. Weinman, Yoland Smith, Randy A. Hall	11
5	Integrative Analysis of Genetic, Genomic, and Phenotypic Data for Ethanol Behaviors: A Network-Based Pipeline for Identifying Mechanisms and Potential Drug Targets 2016 ·Methods in molecular biology ·James W. Bogenpohl, (unknown), Maren L. Smith, Michael F. Miles	4
6	Metabotropic glutamate receptor 4 in the basal ganglia of parkinsonian monkeys: Ultrastructural localization and electrophysiological effects of activation in the striatopallidal complex 2012 ·Neuropharmacology ·James W. Bogenpohl, Adriana Galván, Xing Hu, Thomas Wichmann, Yoland Smith	37
7	Adenosine A_2Areceptor in the monkey basal ganglia: Ultrastructural localization and colocalization with the metabotropic glutamate receptor 5 in the striatum 2011 ·The Journal of Comparative Neurology ·James W. Bogenpohl, (unknown), Randy A. Hall, Yoland Smith	35
8	Discovery, Synthesis, and Structure–Activity Relationship Development of a Series of N-4-(2,5-Dioxopyrrolidin-1-yl)phenylpicolinamides (VU0400195, ML182): Characterization of a Novel Positive Allosteric Modulator of the Metabotropic Glutamate Receptor 4 (mGlu₄) with Oral Efficacy in an Antiparkinsonian Animal Model 2011 ·Journal of Medicinal Chemistry ·Carrie K. Jones, Darren W. Engers, Analisa D. Thompson, Julie R. Field, Anna L. Blobaum, Stacey R. Lindsley, Ya Zhou, Rocco D. Gogliotti, Satyawan Jadhav, Rocio Zamorano, James W. Bogenpohl, Yoland Smith, Ryan D. Morrison, J. Scott Daniels, C. David Weaver, P. Jeffrey Conn, Craig W. Lindsley, Colleen M. Niswender, Corey R. Hopkins	50
9	Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys 2011 ·Brain ·Gunasingh Masilamoni, James W. Bogenpohl, David Alagille, Kristen Delevich, Gilles Tamagnan, John R. Votaw, Thomas Wichmann, (unknown)	95
10	Behavioral responses of dopamine β-hydroxylase knockout mice to modafinil suggest a dual noradrenergic–dopaminergic mechanism of action 2008 ·Pharmacology Biochemistry and Behavior ·Heather A. Mitchell, James W. Bogenpohl, L. Cameron Liles, Michael P. Epstein, Donna Bozyczko‐Coyne, Michael Williams, David Weinshenker	43
11	The imprinted gene Magel2 regulates normal circadian output 2007 ·Nature Genetics ·С. В. Козлов, James W. Bogenpohl, (unknown), Rachel Wevrick, (unknown), John B. Hogenesch, Louis J. Muglia, Russell N. Van Gelder, Erik D. Herzog, Colin L. Stewart	161
12	Comparison of dot chromosome sequences from D. melanogaster and D. virilisreveals an enrichment of DNA transposon sequences in heterochromatic domains 2006 ·Genome biology ·(unknown), C. Shaffer, Colin D. Malone, Wilson Leung, (unknown), (unknown), Carolyn A. Craig, Seth M. Bloom, James W. Bogenpohl, (unknown), (unknown), (unknown), Andrew Nett, Fatih Ozsolak, (unknown), (unknown), Mary‐Lou Pardue, Jeremy Buhler, Elaine R. Mardis, Sarah C. R. Elgin	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact